RBC Capital Markets raised its recommendation on KB Home (NYSE:KBH) and Lennar (NYSE:LEN), considering the homebuilders' ...
Find insight on BBVA, Australia’s banks and more in the latest Market Talks covering Financial Services.
RBC Capital Markets maintained a cautious outlook on homebuilders for 2025 given the affordability challenges amid high ...
“The Bank of Canada (BoC) already flagged in December that with interest rates no longer clearly at 'restrictive' levels, and ...
Morgan Stanley upgraded Gilead (GILD) to Overweight from Equal Weight with a price target of $113, up from $87. The firm sees ...
A hot jobs report makes it even more likely the Federal Reserve won’t cut rates at its next meeting in January — or for the foreseeable future.
In a report released on January 7, Luca Issi from RBC Capital maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...
Employers added 256,000 jobs in December despite uncertainty over President-elect Donald Trump's policies. Unemployment dipped to 4.1% ...
In recent days, Fed Chair Jerome Powell and other officials have made it clear they're slowing down on lowering rates. Amid that tone and after the jobs showing, markets are pricing in no easing ...
The volume of cash in circulation in Russia in 2024 appears to have experienced its weakest growth in nine years, according ...
For those who don’t want other bank products, mortgage rates can sometimes be 10 to 15 basis points higher. On a standard new $500,000 mortgage with 25-year amortization, an additional 15 basis points ...
Investing.com -- Shares of Apellis Pharmaceuticals (NASDAQ: APLS) fell 8.9% in premarket trading following news that the FDA accepted a revised supplemental application from competitor Astellas Pharma ...